Surgery may improve survival in metastatic breast cancer

04/1/2013 | U.S. News & World Report

A German study found patients with metastatic breast cancer who underwent surgery to remove lung tumors had an average survival rate of 103 months in cases of complete removal, and 20 to 23 months in those whose tumors could not be completely removed. The results suggest physicians should consider surgery in such patients, researchers wrote in The Annals of Thoracic Surgery.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY